Company Monitoring Page for Sarepta

latest headlines for company on cafepharma

Sarepta And Eteplirsen: Will 12 Patients Be Enough For The FDA?
Seeking Alpha
Wed, 06/19/13 - 10:33 am
Tags:
Sarepta, eteplirsen, FDA, GSK, Duchenne Muscular Dystrophy
3 Biotech Stocks With Potential
Seeking Alpha
Tue, 05/14/13 - 10:13 am
Tags:
Keryx, NeoStem, ImmunoCellular Therapeutics, Sarepta
Sarepta's Meaningless Q1 Results
Motley Fool
Thu, 05/9/13 - 11:58 am
Tags:
earnings, Sarepta
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Tags:
Vertex Pharmaceuticals, Pharmacyclics, Novartis, Celsion, Peregrine Pharmaceuticals, Prana, Navidea Biopharmaceuticals, Cardinal Health, ONYX Pharmaceuticals, Bayer, Sarepta, Hyperion Therapeutics, Amarin, Medivation, Astellas, JNJ, Trius, Sangamo BioSciences
[video]3 Biggest Biotech Crashes in April
Motley Fool
Thu, 05/2/13 - 10:36 am
Tags:
Dyax, Rigel Pharmaceuticals, Sarepta, AstraZeneca
Sarepta Therapeutics: Irrational Exuberance
Seeking Alpha
Thu, 04/25/13 - 09:24 am
Tags:
Sarepta, GSK, eteplirsen, Duchenne Muscular Dystrophy
Quickly Approaching Biopharma Catalyst Events
Seeking Alpha
Wed, 04/24/13 - 10:27 am
Tags:
Agenus, Aveo Pharmaceuticals, Insmed, GSK, Sarepta
FDA Says, "Call Me Maybe"
Motley Fool
Thu, 04/18/13 - 06:55 pm
Tags:
FDA, Sarepta, eteplirsen
2 Views on Sarepta's FDA News
Motley Fool
Tue, 04/16/13 - 12:02 pm
Tags:
FDA, Duchenne Muscular Dystrophy, Sarepta, eteplirsen
Sarepta tumbles after FDA requests more data on drug
The Fly on the Wall
Tue, 04/16/13 - 10:49 am
Tags:
FDA, Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Sarepta Fans: A Single Data Slide Raises Questions About Glaxo's DMD Drug
TheStreet.com
Fri, 04/12/13 - 01:28 pm
Tags:
Sarepta, GSK, Duchenne Muscular Dystrophy, drisapersen, eteplirsen
Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In
Seeking Alpha
Thu, 04/11/13 - 11:33 am
Tags:
Duchenne Muscular Dystrophy, Sarepta, GSK, eteplirsen, drisapersen, Prosensa
Glaxo's Drisapersen Data Revealed Early
TheStreet.com
Tue, 04/9/13 - 04:02 pm
Tags:
GSK, drisapersen, eteplirsen, Sarepta, Duchenne Muscular Dystrophy
Sarepta-Glaxo Duchenne's Rivalry Heats Up This Week
TheStreet.com
Mon, 04/8/13 - 11:27 am
Tags:
GSK, Sarepta, Duchenne Muscular Dystrophy, drisapersen, Prosensa, eteplirsen
Sarepta's Eteplirsen Boys Keep On Walking
TheStreet.com
Fri, 04/5/13 - 10:45 am
Tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
3 Small Cap Biopharmas Primed To Move Much Higher Now
Seeking Alpha
Wed, 03/27/13 - 12:27 pm
Tags:
Acadia, Aveo Pharmaceutical, Sarepta
Sarepta set to rise if seeks quick drug OK
Reuters
Mon, 03/25/13 - 11:09 am
Tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
DB Analyst Gets It: Sarepta Is a Winner Even Without Accelerated Approval
TheStreet.com
Tue, 03/19/13 - 11:14 am
Tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tue, 03/12/13 - 11:45 am
Tags:
Arena Pharmaceuticals, Sarepta, Ziopharm, Delcath, Aveo Pharmaceutical, United Therapeutics, AP Pharma, Titan Pharmaceuticals, Navidea Biopharmaceuticals, Biogen Idec, Raptor Pharmaceuticals
Investors Seeing Huge Potential In RNA Drug Developers
Seeking Alpha
Fri, 03/8/13 - 11:17 am
Tags:
Sarepta, RXi Pharmaceuticals, OPKO, Alnylam

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.